As we head into November, keep an eye out for fiscal year-end updates from Bloom Health Partners (CSE: BLMH). With the company currently trading at all-time lows, the catalyst potential for its year-end report is very high.
The company is currently trading at less than of its anticipated earnings, representing a massing undervaluation.
BLMH.c is currently trading at $.125, valued at $5.96 million.
https://ceo.ca/blmh